National Cancer Institute; Notice of Closed Meetings, 7051 [07-649]
Download as PDF
Federal Register / Vol. 72, No. 30 / Wednesday, February 14, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
ycherry on PROD1PC64 with PRELIMS
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Develop
Automated Methods to Identify
Environmental Exposure Patterns in Satellite
Imagery Data.
Date: March 6, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 611, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Rhonda J. Moore, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Suite 701, Room 7151, Bethesda, MD 20892–
8329, 301–451–9385, morerh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Innovations in Cancer Sample Preparation.
Date: March 14, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 210, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Administrator,
Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd.,
Rm. 8057, Bethesda, MD 20892–8329, 301–
496–7421, kerwinm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Software
Systems Population Based Cancer
Surveillance Data.
Date: March 15, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
VerDate Aug<31>2005
17:27 Feb 13, 2007
Jkt 211001
Place: National Institutes of Health, 6116
Executive Boulevard, Room 611, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Rhonda J. Moore, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Suite 701, Room 7151, Bethesda, MD 20892–
8329, 301–451–9385, morerh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, using
Social Marketing to Disseminate EvidenceBased Energy Balance Intervention,
Approaches to Worksites.
Date: March 20, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 611, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Rhonda J. Moore, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Suite 701, Room 7151, Bethesda, MD 20892–
8329, 301–451–9385, morerh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Small
Grants for Behavioral Research in Cancer
Control.
Date: March 29, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd. 7149,
Bethesda, MD 20892, 301–594–1286,
peguesj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Application of Emerging Technologies for
Cancer Research.
Date: April 3–4, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Marvin L. Salin, PhD,
Scientific Review Administrator, National
Cancer Institute, Special Review and
Logistics Branch, Division of Extramural
Activities, 6116 Executive Boulevard, Room
7073, MSC8329, Bethesda, MD 20892–8329,
301–496–0694, msalin@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
7051
Dated: February 2, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–649 Filed 2–13–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group, Genome Research Review Committee.
Date: March 8, 2007.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Keith McKenney, PhD,
Scientific Review Administrator, NHGRI,
5635 Fishers Lane, Suite 4076, MSC 9306,
Bethesda, MD 20814, 301–594–4280,
mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: February 7, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–646 Filed 2–13–07; 8:45 am]
BILLING CODE 4140–07–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\14FEN1.SGM
14FEN1
Agencies
[Federal Register Volume 72, Number 30 (Wednesday, February 14, 2007)]
[Notices]
[Page 7051]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-649]
[[Page 7051]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Develop Automated Methods to Identify Environmental Exposure
Patterns in Satellite Imagery Data.
Date: March 6, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 611, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Rhonda J. Moore, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Boulevard, Suite 701, Room 7151, Bethesda, MD 20892-8329,
301-451-9385, morerh@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Innovations in Cancer Sample Preparation.
Date: March 14, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 210, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: C. Michael Kerwin, PhD, MPH, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Rm. 8057, Bethesda, MD 20892-8329, 301-496-7421,
kerwinm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Software Systems Population Based Cancer Surveillance Data.
Date: March 15, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 611, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Rhonda J. Moore, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Boulevard, Suite 701, Room 7151, Bethesda, MD 20892-8329,
301-451-9385, morerh@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, using Social Marketing to Disseminate Evidence-Based Energy
Balance Intervention, Approaches to Worksites.
Date: March 20, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 611, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Rhonda J. Moore, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Boulevard, Suite 701, Room 7151, Bethesda, MD 20892-8329,
301-451-9385, morerh@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Small Grants for Behavioral Research in Cancer Control.
Date: March 29, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Joyce C. Pegues, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Blvd. 7149, Bethesda, MD 20892, 301-594-1286, peguesj@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Application of Emerging Technologies for Cancer Research.
Date: April 3-4, 2007.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Marvin L. Salin, PhD, Scientific Review
Administrator, National Cancer Institute, Special Review and
Logistics Branch, Division of Extramural Activities, 6116 Executive
Boulevard, Room 7073, MSC8329, Bethesda, MD 20892-8329, 301-496-
0694, msalin@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 2, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-649 Filed 2-13-07; 8:45 am]
BILLING CODE 4140-01-M